FDA Inspection
Mission Pharmacal CompanyMission Pharmacal Company – FDA Inspection, Apr 4, 2019
Record Details
This FDA Inspection record concerns Mission Pharmacal Company, with an inspection on April 4, 2019, issued by the Dallas District Office, covering human drugs.
View Company Profile
ID · 9828023a-ad18-41ad-b502-0f962d22608b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1085124
- FDA center
- Human Drugs
- Project area
- New Drug Evaluation
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.194(a)(4)Complete Test Data
- 21 CFR 211.58Buildings not maintained in good state of repair
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Mission Pharmacal Company
8| Date | Classification | Office | Project area |
|---|---|---|---|
| June 27, 2023 | NAI | Center for Food Safety and Applied Nutrition | Food Composition, Standards, Labeling and Econ |
| September 22, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 20, 2018 | NAI | Center for Food Safety and Applied Nutrition | Foodborne Biological Hazards |
| May 4, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 7, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Mission Pharmacal Company
- FDA Inspection 1219105 - 2023-06-27
- FDA Inspection 1180935 - 2022-09-22
- FDA Inspection 1067651 - 2018-09-20
- FDA Inspection 1019109 - 2017-05-04
- FDA Inspection 866629 - 2014-02-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.